epidemiolog
clinic
studi
shown
environment
factor
infect
smoke
vitamin
associ
risk
develop
multipl
sclerosi
ms
factor
also
play
role
ms
diseas
cours
current
begin
understand
environment
factor
may
impact
immun
function
ms
cellular
molecular
level
review
epidemiolog
clinic
basic
immunolog
studi
environment
factor
viral
parasit
infect
smoke
vitamin
relat
epidemiolog
find
like
pathophysiolog
ms
multipl
sclerosi
ms
inflammatori
diseas
central
nervou
system
cn
interplay
genet
environment
factor
lead
chronic
activ
immun
cell
neuron
injuri
epidemiolog
studi
identifi
sever
environment
risk
factor
ms
includ
exposur
certain
virus
smoke
convers
lack
exposur
sunlight
correl
increas
risk
ms
factor
associ
suscept
develop
ms
recent
studi
show
factor
also
impact
ms
diseas
cours
howev
identif
environment
risk
factor
ms
made
difficult
fact
singl
risk
factor
isol
appear
respons
develop
diseas
like
multifactori
interplay
factor
determin
suscept
ms
well
diseas
cours
given
mani
possibl
factor
may
influenc
ms
suscept
diseas
cours
studi
need
larg
enough
data
need
high
qualiti
determin
impact
individu
possibl
risk
factor
exampl
diet
exposur
organ
solvent
may
play
role
ms
investig
risk
factor
difficult
high
qualiti
data
factor
long
observ
period
often
avail
result
studi
factor
therefor
less
reliabl
sometim
contradictori
articl
provid
overview
immunopathogenesi
ms
discuss
environment
factor
may
affect
aspect
immun
function
ms
etiolog
ms
unresolv
one
hypothesi
postul
variou
class
immun
cell
activ
peripheri
enter
cn
produc
patholog
altern
hypothesi
infer
initi
dysfunct
within
cn
need
immunolog
inflammatori
potenti
patholog
process
includ
mitochondri
dysfunct
neuron
oligodendrocyt
axon
energi
insuffici
inactiv
neural
organel
peroxisom
follow
initi
injuri
leakag
cn
antigen
drain
lymph
node
contribut
activ
cell
immun
cell
subset
enter
cn
thu
whatev
origin
ms
patholog
result
activ
recruit
immun
cell
subset
cn
produc
hallmark
ms
patholog
demyelin
oligodendrocyt
loss
axonalneuron
injuri
loss
antigen
present
fig
necessari
activ
cell
commonli
pathogen
expos
tissu
engulf
broken
antigen
present
cell
apc
dendrit
cell
apc
migrat
lymph
node
carri
short
segment
pathogen
antigen
bound
major
histocompat
complex
mhc
cell
surfac
lymph
node
antigen
present
cell
tcell
receptor
tcr
recogn
antigenmhc
combin
becom
initi
engag
antigen
mhc
tcr
interact
constitut
first
signal
second
signal
mediat
costimulatori
molecul
eg
antigen
present
cell
cell
necessari
tcell
undergo
activ
prolifer
subsequ
differenti
effector
cell
cell
activ
engag
tcr
cell
antigenmhc
class
complex
cell
activ
engag
tcr
cell
antigenmhc
class
ii
complex
cell
particularli
interest
ms
differenti
proinflammatori
helper
th
subset
antiinflammatori
cell
cell
regulatoryantiinflammatori
properti
treg
depend
microenviron
cytokin
milieu
cell
ms
patient
tend
differenti
andor
subset
proinflammatori
potenti
neurotox
well
contrast
propens
gener
appar
defici
regulatori
antiinflammatori
treg
subset
ms
whole
favor
proinflammatori
milieu
besid
subset
cell
also
sever
tissu
damag
role
ms
b
cell
also
import
contributor
diseas
activ
ms
best
support
evid
monoclon
antibodi
b
cell
fig
step
immunopathogenesi
ms
modul
environment
factor
initi
activ
cell
antigen
present
cell
peripheri
particularli
lymph
node
lead
increas
gener
andor
proinflammatori
subset
ms
cell
leukocyt
subset
includ
monocyt
b
cell
transit
blood
adher
onto
inflam
endotheli
cell
ec
predominantli
postcapillari
venul
cn
leukocyt
popul
produc
mmp
invad
across
glia
limitan
cn
parenchyma
cell
may
undergo
reactiv
within
cn
togeth
leukocyt
popul
enter
cn
contribut
tissu
injuri
figur
also
display
environment
factor
influenc
ms
may
act
cascad
immunopathogenesi
target
b
cell
antigen
effect
therapi
ms
oligoclon
band
cerebrospin
fluid
repres
immunoglobulin
mani
specif
common
ms
patient
b
cell
follicularlik
structur
found
mening
mani
patient
ms
besid
product
antibodi
target
cn
structur
protein
node
ranvier
pathogen
role
b
cell
thought
relat
cellular
function
antigen
present
provid
help
cell
activ
immun
cell
upregul
variou
adhes
molecul
adher
endotheli
cell
postcapillari
venul
cn
cross
endotheli
cell
barrier
immun
cell
readili
cross
endotheli
basement
membran
presenc
proteolyt
activ
larg
furnish
famili
matrix
metalloproteinas
mmp
migrat
across
second
basement
membran
barrier
glia
limitan
parenchym
basement
membran
cn
parenchyma
fig
without
proteolyt
activ
immun
cell
trap
perivascular
space
separ
basement
membran
layer
howev
mmp
upregul
ms
facilit
transmigr
activ
immun
cell
cn
parenchyma
mmp
induc
upstream
switch
extracellular
matrix
metalloproteinas
induc
emmprin
upon
enter
cn
parenchyma
cell
becom
reactiv
repeat
antigen
present
apc
microglia
macrophag
b
cell
dendrit
cell
product
activ
immun
cell
subset
includ
free
radic
glutam
excitotoxin
proteas
cytokin
caus
promot
neuron
injuri
loss
find
migrat
studi
led
idea
viral
infect
may
trigger
develop
ms
sever
studi
shown
peopl
migrat
countri
high
ms
preval
one
lower
preval
lower
risk
develop
ms
would
countri
origin
migrat
lowrisk
countri
highrisk
one
retain
low
risk
countri
origin
children
risk
compar
countri
emigr
review
see
studi
suggest
effect
migrat
risk
develop
ms
stronger
migrat
age
suggest
infect
young
age
may
predispos
later
develop
ms
addit
migrat
studi
classic
studi
incid
preval
ms
suggest
may
ms
epidem
sever
locat
rise
ms
incid
second
world
war
faro
island
best
known
exampl
similar
increas
shetland
island
ferrara
sardinia
taken
suggest
infecti
agent
may
involv
pathogenesi
ms
sever
virus
implic
factor
may
influenc
ms
risk
includ
epsteinbarrviru
ebv
herp
simplex
viru
hsv
type
human
herpesviru
measl
mump
rubella
evid
role
virus
ms
inconsist
except
support
ebv
studi
influenc
ebv
ms
gener
difficult
due
high
preval
ebv
seroposit
gener
popul
around
seroposit
adulthood
translat
larg
sampl
size
achiev
adequ
power
epidemiolog
studi
despit
methodolog
challeng
seroneg
ebv
associ
low
risk
ms
metaanalysi
includ
ms
patient
nonm
control
show
ci
develop
ms
seroneg
person
compar
seroposit
histori
symptomat
ebv
infect
infecti
mononucleosi
hand
roughli
doubl
risk
develop
ms
shown
recent
meta
analysi
includ
patient
control
rel
risk
ci
studi
associ
ebv
diseas
cours
ms
shown
diverg
result
one
small
prospect
cohort
studi
n
found
patient
higher
serum
antibodi
titer
ebv
earli
antigen
ea
significantli
gadolinium
enhanc
lesion
mri
disabl
clinic
characterist
differ
anoth
prospect
cohort
studi
follow
patient
period
five
year
found
signific
rel
weak
correl
spearman
rank
correl
r
serum
antiepstein
barr
nuclear
igg
titer
number
gadolinium
enhanc
lesion
chang
lesion
volum
chang
edss
score
possibl
influenc
ebv
earli
stage
diseas
process
ms
investig
anoth
cohort
studi
compar
patient
ci
match
control
increas
level
serum
igg
titer
found
among
ci
patient
well
signific
although
weak
correl
serum
igg
titer
gadolinium
enhanc
lesion
number
lesion
edss
score
spearman
rank
correl
appar
relationship
ebv
antibodi
titer
measur
diseas
activ
consist
found
howev
ingram
cowork
found
correl
serum
igg
titer
edss
msss
score
investig
ms
patient
observ
studi
compar
healthi
control
ms
patient
limit
analys
ebv
serolog
clearer
pictur
recent
emerg
studi
differ
control
pohl
colleagu
found
elev
antibodi
indic
ebv
also
neurotrop
virus
csf
serum
children
adult
ms
interestingli
antibodi
indic
measl
rubella
varicella
zoster
viru
herp
simplex
viru
higher
ebv
suggest
humor
immun
respons
elev
ebv
titer
ms
exclus
direct
ebv
antigen
part
gener
polyspecif
immun
respons
find
confirm
similar
studi
patient
ci
ms
sever
hypothes
explain
viral
infect
associ
ms
one
hypothesi
bystand
activ
postul
autoreact
cell
activ
nonspecif
inflammatori
molecul
occur
infect
cytokin
superantigen
tolllik
receptor
ligand
yet
anoth
hypothesi
virus
activ
immun
cell
process
molecular
mimicri
hypothesi
postul
upon
exposur
pathogen
pathogenmhc
conform
apc
bear
molecular
similar
endogen
peptid
fragment
myelin
basic
protein
mbp
present
within
mhc
costimulatori
molecul
properli
engag
result
could
expans
differenti
pathogenreact
cell
properli
direct
immun
respons
also
expans
mbpreactiv
cell
improp
outcom
pool
differenti
proinflammatori
subset
fig
becom
reactiv
within
cn
promot
patholog
support
idea
cell
line
isol
ms
patient
demonstr
crossreact
mbp
coronaviru
ebv
antigen
moreov
crystal
structur
analys
reveal
signific
degre
structur
similar
peptid
complex
peptid
complex
cell
surfac
tcr
recognit
overal
given
sever
pathogen
molecular
similar
number
myelin
peptid
molecul
within
cn
probabl
high
sever
virus
lead
improp
expans
cnsreactiv
cell
promot
patholog
within
cn
reason
difficult
pinpoint
singl
infecti
pathogen
uniqu
associ
ms
immunolog
base
associ
ebv
ms
follicularlik
structur
mening
harbor
b
cell
infect
ebv
mani
patient
thought
trojan
horselik
mechan
ebv
infect
brain
ms
subject
antibodi
crossreact
mbp
ebv
provid
mechan
ebvreact
antibodi
may
disrupt
myelin
moreov
cellular
immun
respons
ebvreact
cell
restrict
common
allel
ms
dysregul
ms
pender
postul
initi
cell
defici
ms
impair
capac
control
ebv
infect
result
ebvinfect
b
cell
accumul
cn
produc
pathogen
autoantibodi
provid
surviv
signal
autoreact
cell
although
evid
parasit
infect
impact
ms
risk
may
impact
diseas
activ
report
singl
ms
center
argentina
note
patient
relapsingremit
ms
patient
eosinophilia
caus
mild
asymptomat
intestin
parasitosi
patient
compar
age
gendermatch
relapsingremit
ms
group
evid
intestin
parasit
prospect
follow
seven
year
interestingli
number
new
relaps
accumul
disabl
number
new
enhanc
lesion
mri
much
lower
parasit
infect
group
uninfect
control
group
four
patient
becam
symptomat
regard
infect
receiv
antiparasit
medic
result
clear
parasit
infect
experienc
increas
relaps
mri
lesion
disabl
find
encourag
other
undertak
pilot
trial
five
relapsingremit
ms
patient
treatment
consist
parasit
introduc
ingest
helminth
egg
preliminari
result
show
number
new
enhanc
mri
lesion
reduc
treatment
exposur
parasit
result
characterist
immunolog
respons
aim
erad
parasit
helper
cell
respons
predominantli
bias
increas
frequenc
regulatori
cell
regulatori
b
cell
amongst
other
balanc
antiinflammatori
regulatori
return
activ
immun
respons
back
homeostasi
context
ms
elev
antiinflammatori
regulatori
immun
respons
would
help
overcom
proinflammatori
condit
seen
ms
inde
infect
ms
patient
describ
argentinean
studi
higher
level
antiinflammatori
cell
regulatori
b
cell
compar
uninfect
ms
control
group
smoke
recent
recogn
environment
risk
factor
ms
convinc
evid
smoke
increas
suscept
ms
come
analysi
nurs
health
studi
show
rel
incid
rate
ms
current
smoker
compar
never
smoker
confid
interv
ci
doserespons
depend
pack
year
smoke
two
studi
also
shown
second
hand
smoke
exposur
increas
risk
develop
ms
among
children
adjust
rate
ratio
ci
adult
ci
smoke
also
seem
impact
inflammatori
outcom
ms
studi
patient
clinic
isol
syndrom
ci
show
increas
risk
convers
clinic
definit
ms
smoker
compar
nonsmok
hr
confid
interv
one
imag
crosssect
studi
show
smoker
gadolinium
enhanc
lesion
greater
load
brain
atrophi
nonsmok
anoth
studi
follow
patient
averag
year
report
quicker
increas
lesion
volum
brain
atrophi
smoker
associ
smoke
diseas
progress
howev
less
clear
studi
hospit
base
ms
cohort
suggest
smoke
neither
associ
risk
secondari
progress
hr
ci
reach
edss
hr
ci
edss
hr
ci
analysi
data
collect
gener
practition
howev
suggest
smoke
associ
greater
risk
evolv
secondari
progress
cours
hazard
ratio
hr
ci
recent
larg
hospit
base
cohortstudi
also
found
smoke
associ
risk
secondari
progress
hr
ci
increas
edss
score
prospect
australian
studi
smoke
associ
increas
edss
score
two
year
followup
thu
appear
smoke
influenc
earli
diseas
cours
ms
research
need
ascertain
rel
impact
earli
versu
late
diseas
stage
ms
known
smoke
increas
risk
ms
although
cigarett
smoke
contain
mani
mutagen
potenti
may
affect
long
last
immun
recent
review
indic
smoke
gener
lead
immunosuppress
state
nonetheless
aspect
immun
function
promot
cigarett
smoke
genet
studi
indic
interact
smoke
gene
regul
immun
function
may
instruct
determin
whether
constitu
tobacco
alter
signal
aryl
hydrocarbon
receptor
transcript
factor
affect
polycycl
aromat
hydrocarbon
polychlorin
dioxin
latter
regul
cell
polar
alter
cours
experiment
autoimmun
encephalomyel
anim
model
ms
one
potenti
mechan
smoke
affect
ms
upregul
mmp
sinc
immun
cell
biolog
fluid
smoker
tend
higher
level
sever
mmp
higher
express
mmp
smoker
could
advantag
immun
cell
cross
blood
brain
barrier
cn
parenchyma
noteworthi
comparison
mri
scan
smoker
nonsmok
ms
show
contrast
enhanc
lesion
among
smoker
suggest
increas
breakdown
blood
brain
barrier
ms
preval
region
higher
latitud
shown
mani
popul
recent
phenomenon
associ
sunlight
uv
exposur
subsequ
product
vitamin
retrospect
studi
van
der
mei
colleagu
show
risk
ms
decreas
peopl
greater
exposur
sunlight
recent
demonstr
risk
develop
ms
decreas
increas
serum
level
ci
per
nmoll
increas
prospect
nest
casecontrol
studi
level
routin
serum
sampl
relat
subsequ
risk
develop
ms
us
militari
personnel
studi
calcul
risk
ms
pose
variou
suspect
environment
factor
ms
lack
uv
exposur
found
signific
risk
factor
also
mount
evid
vitamin
influenc
diseas
cours
ms
crosssect
studi
show
low
level
vitamin
one
consequ
low
vitamin
level
lower
bone
miner
densiti
common
ms
lower
vitamin
level
associ
higher
level
disabl
evid
associ
vitamin
relaps
come
prospect
cohort
studi
show
decreas
risk
relaps
subsequ
six
month
patient
higher
serum
vitamin
level
hr
per
nmoll
increas
ci
retrospect
cohort
studi
show
similar
result
children
ms
also
evid
suggest
vitamin
supplement
may
effect
treatment
ms
burton
cowork
perform
random
control
trial
investig
highdos
vitamin
treatment
ms
found
trend
toward
decreas
relaps
treatment
although
immun
modulatori
mechan
potenti
exist
ultraviolet
radiat
associ
sunlight
ms
like
due
ultraviolet
b
radiat
sunlight
nm
convert
cutan
previtamin
spontan
form
vitamin
latter
undergo
hydroxyl
notabl
liver
kidney
produc
biolog
activ
form
vitamin
notabl
variant
gene
found
associ
increas
risk
ms
anoth
studi
found
associ
ms
second
region
contain
anoth
vitamin
associ
gene
vitamin
respons
element
lie
close
promot
region
main
risk
allel
ms
util
vitamin
ms
almost
certainli
due
multipl
immuneregul
properti
impact
major
immunopathogen
step
outlin
fig
vitamin
suppress
matur
activ
apc
includ
dendrit
cell
increas
tolerogen
phenotyp
therebi
reduc
probabl
present
selfantigen
gener
autoreact
cell
decreas
likelihood
expand
autoreact
cell
molecular
mimicri
differenti
helper
cell
also
affect
vitamin
reduc
product
proinflammatori
cell
concurr
cell
increas
therebi
help
reduc
proinflammatori
state
typifi
ms
major
immunolog
consequ
vitamin
treatment
increas
activ
regulatori
cell
reduct
proinflammatori
molecul
produc
stimul
monocyt
immunolog
chang
caus
vitamin
detect
cultur
sampl
obtain
ms
patient
eae
eae
treatment
vitamin
either
prevent
develop
symptom
given
earli
diseas
cours
reduc
sever
eae
treatment
initi
onset
clinic
sign
peak
diseas
vitamin
known
penetr
cn
may
potenti
sever
activ
within
cn
includ
reduct
antigen
present
reduc
neuroinflamm
intrigu
possibl
vitamin
may
neuroprotect
enzym
necessari
synthes
bioactiv
present
brain
rat
defici
vitamin
gestat
abnorm
brain
develop
alter
brain
shape
enlarg
later
ventricl
volum
observ
mice
gestat
vitamin
defici
impair
learn
adulthood
tissu
cultur
glutam
excitotox
cortic
cerebellar
hippocamp
neuron
reduc
vitamin
extent
neuroprotect
activ
vitamin
account
effect
ms
remain
clarifi
overal
substanti
evid
vitamin
correct
mani
immun
abnorm
seen
ms
clear
multipl
mechan
critic
therapeut
efficaci
whether
benefit
vitamin
may
relat
action
within
cn
remain
determin
point
separ
field
ms
epidemiolog
basic
laboratori
research
come
togeth
improv
overal
understand
diseas
process
ms
recent
epidemiolog
studi
identifi
new
risk
factor
associ
risk
develop
ms
also
perhap
immedi
import
ms
diseas
cours
previou
factor
associ
ms
diseas
cours
gender
age
diseas
onset
modifi
newli
identifi
factor
smoke
vitamin
level
modifi
individu
public
health
measur
futur
studi
risk
factor
ms
need
build
upon
classic
epidemiolog
studi
integr
new
factor
big
pictur
studi
need
unravel
whole
set
classic
newli
identifi
factor
interact
modul
immunomodulatori
drug
genet
factor
gender
hormon
stage
diseas
greatest
impact
basic
laboratori
research
help
us
understand
mechan
underli
epidemiolog
associ
hope
lead
use
experiment
model
eventu
new
treatment
author
declar
conflict
interest
